Results 1 to 10 of about 93,467 (314)

Meta-analysis of the efficacy and adverse drug reactions of adrenergic alpha-antagonists in treating children with ureteral calculi [PDF]

Frontiers in Pediatrics, 2023
This meta-analysis investigated the efficacy and adverse drug reactions (ADRs) of three different adrenergic alpha-antagonists during the treatment of pediatric ureteral stones.
Kai Sun, Peizhi Zhang, Yanning Sun, Qingliang Wang, Qinghua Xia, Qinghua Xia   +5 more
doaj   +7 more sources

Do adrenergic alpha‐antagonists increase the risk of poor cardiovascular outcomes? A systematic review and meta‐analysis [PDF]

ESC Heart Failure, 2022
Due to concerns regarding neurohormonal activation and fluid retention, adrenergic alpha‐1 receptor antagonists (A1Bs) are generally avoided in the setting of heart disease, namely, symptomatic heart failure (HF) with reduced ejection fraction (HFrEF ...
José Pedro Sousa, Diogo Mendonça, Rogério Teixeira, Lino Gonçalves   +3 more
doaj   +7 more sources

6ER-018 The effectiveness of adrenergic alpha antagonists on reducing re-catheterisation rates in adults with urinary catheters: a systematic review and meta-analysis [PDF]

Section 6: Education and research
YT Chen, C Kai-Cheng, C Hui-Yu
semanticscholar   +3 more sources

Alpha-adrenergic antagonists and iris dynamics: Challenges and solutions in cataract surgery [PDF]

BMC Ophthalmology
Background Alpha-1 adrenergic receptor antagonists (α1-ARAs) are frequently used in treatment of Hypertension and symptomatic benign prostatic hypertrophy (BPH).
Jaya Kaushik, Rishi Sharma, Sumit Goyal, Meenu Dangi, Rakesh Kumar Jha, Ankita Singh   +5 more
doaj   +3 more sources

Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing

BMC Geriatrics, 2022
Background Adrenergic alpha-1 receptor antagonists (alpha-1 antagonists) are frequently used medications in the management of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) and in the management of therapy-resistant ...
Felix Mansbart, Gerda Kienberger, Andreas Sönnichsen, Eva Mann   +3 more
doaj   +2 more sources

Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection

eLife, 2021
In severe viral pneumonia, including Coronavirus disease 2019 (COVID-19), the viral replication phase is often followed by hyperinflammation, which can lead to acute respiratory distress syndrome, multi-organ failure, and death.
Allison Koenecke, Michael Powell, Ruoxuan Xiong, Zhu Shen, Nicole Fischer, Sakibul Huq, Adham M Khalafallah, Marco Trevisan, Pär Sparen, Juan J Carrero, Akihiko Nishimura, Brian Caffo, Elizabeth A Stuart, Renyuan Bai, Verena Staedtke, David L Thomas, Nickolas Papadopoulos, Ken W Kinzler, Bert Vogelstein, Shibin Zhou, Chetan Bettegowda, Maximilian F Konig, Brett D Mensh, Joshua T Vogelstein, Susan Athey   +24 more
doaj   +2 more sources

Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction [PDF]

Frontiers in Oncology, 2016
Background Stereotactic body radiation therapy (SBRT) delivers high doses of radiation to the prostate while minimizing radiation to the adjacent critical organs.
Michael Repka, Shan Guleria, Robyn A. Cyr, Thomas Yung, Harsha Koneru, Leonard N. Chen, Siyuan Lei, Brian T. Collins, Pranay Krishnan, Simeng Suy, Anatoly Dritschilo, John H. Lynch, Sean P. Collins   +12 more
openalex   +2 more sources

Quantitative relationships between .alpha.-adrenergic activity and binding affinity of .alpha.-adrenoceptor agonists and antagonists

Journal of Medicinal Chemistry, 1984
Pieter B.M.W.M. Timmermans, A. de Jonge, Martin Thoolen, Bob Wilffert, H. D. Batink, Pieter A. van Zwieten   +5 more
openalex   +2 more sources

Analogs of phosphatidylcholine: alpha-adrenergic antagonists from the renal medulla. [PDF]

HYPERTENSION, 1981
Keith A. Smith, Russell L. Prewitt, Lawrence W. Byers, E. E. Muirhead   +3 more
openalex   +2 more sources

A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists

Journal of Biological Chemistry, 1991
S Suryanarayana, David A. Daunt, Mark von Zastrow, Brian K. Kobilka   +3 more
openalex   +2 more sources